drugset / Trial / NCT00255125
Role of Soy Supplementation in Prostate Cancer Development
RandomizedParallel-groupTriple-blindPrevention
Summary
This is a randomized study evaluating the effectiveness and direct effect a commercial soy supplement has on prostate cancer and normal prostate tissue. Patient will be randomized it either receive placebo or a commercial soy supplement for 2-4 weeks prior to the planned surgery for treatment of their prostate cancer. Patient's blood and prostate tissue will be evaluated to determine the effects of the soy supplement on the prostate tissue.
Timeline
- Start
- 2005-09
- Primary completion
- 2009-04
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Soy Supplement | Unknown | 80 mg | Oral |